Synaptogenix Receives US FDA Approval of IND Application

Synaptogenix, Inc., a growing biopharmaceutical firm developing therapies for neurodegenerative disorders, announced that the Food and Drug Administration (FDA) has approved an Investigational New Drug (IND) application for Bryostatin-1...

Kerala govt to establish institute of organ transplantation in Kozhikode

The Government of Kerala has decided to establish an Institute of Organ and Tissue Transplant at Kozhikode. It is being established as an Apex Institute for research, training and patient care in the area of organ transplantation and allied

National Doctors Day: Honoring Contributions During Challenging Times

In India, the annual celebration of National Doctors Day honors and celebrates the significant contributions that physicians make to the lives of individuals and communities. It gives an opportunity to recognize the crucial efforts of doctors...

PLI Scheme To Bolster Domestic Manufacturing In India's Pharma Sector

India's Production Linked Incentive (PLI) program has prompted significant investments in the pharmaceutical industry with the intention of strengthening domestic manufacturing and decreasing import dependence, as per the data from the Department...

Surgence and Mayo Clinic Partner To innovate Healthcare Supply Chain

Surgence, a cloud-based digital platform developed by Concordance Innovations, a wholly owned subsidiary of Concordance Healthcare Solutions, has announced a collaboration with Mayo Clinic to integrate Surgence into their digital supply chain...

Orchid Pharma and Cipla Team To Unveil New Drug in India

Orchid Pharma Limited, a Chennai-based Indian pharmaceutical firm, has declared the availability of a new drug, cefepime-enmetazobactam, which has been endorsed for the treatment of complex urinary tract infections (cUTI), hospital-acquired...

© 2024 India Pharma Outlook. All Rights Reserved.